A few successful drugs are all that are required for a biotech company to shine. We saw this happen with , a biotech company that grew from $4 billion to $52 billion in market capitalization. Its stock price has risen by 100% in the last three years, owing to the successful rollout of its coronavirus vaccine.

Some biotechs make drugs for difficult-to-treat diseases that will be required regularly for a long time. These businesses have excellent long-term prospects. Let's take a look at two such growth stocks that could give your portfolio a significant boost in the long run.

Image source: Getty Images.

Continue reading

Source Fool.com